FDA OKs Eluxadoline and Rifaximin for IBS With Diarrhea – Medscape



Medscape
FDA OKs Eluxadoline and Rifaximin for IBS With Diarrhea
Medscape
The US Food and Drug Administration (FDA) today approved not one, but two separate drugs to give relief to adults with irritable bowel syndrome and diarrhea (IBS-D). One of the drugs, eluxadoline (Viberzi, Actavis), has a new active ingredient that
FDA Clears Two Treatments for Irritable Bowel Syndrome with DiarrheaWall Street Journal
Actavis: FDA Okays Viberzi To Treat Irritable Bowel Syndrome With DiarrheaNasdaq
FDA Approves Treatments for Irritable Bowel Syndrome with DiarrheaPharmacy Times
FDA.gov –MarketWatch
all 36 news articles »

diarrhea – Google News